Nappi Francesco, Avatar Singh Sanjeet Singh, Santana Orlando, Mihos Christos G
Centre Cardiologique du Nord de Saint-Denis, Paris, France.
Cardiac Surgery, Golden Jubilee National Hospital, Glasgow, UK.
J Thorac Dis. 2018 Jul;10(7):4540-4555. doi: 10.21037/jtd.2018.07.07.
Functional mitral regurgitation (FMR) is one the most common complications of myocardial infarction (MI) in adults carrying a significant clinical and economic burden. Despite specific randomized controlled studies to address its treatment have been performed, there are still a number of questions remained unanswered. Outcomes of surgical repair of FMR are still hampered by a significant rate of recurrence of regurgitation and need for reoperation. Mechanisms underlying failure of repairs still need to be completely clarified and questions regarding the indications and optimal timing for intervention as well as the best suitable operative technique to be applied are still debated. This work will review the current knowledge on FMR including its pathogenic mechanisms, the available treatment strategies, the evidences from trials and observational studies and the potential future directions to address the issues related to its treatment.
功能性二尖瓣反流(FMR)是成人心肌梗死(MI)最常见的并发症之一,带来了重大的临床和经济负担。尽管已经开展了针对其治疗的特定随机对照研究,但仍有许多问题未得到解答。FMR手术修复的结果仍受到反流复发率高和再次手术需求的阻碍。修复失败的潜在机制仍需完全阐明,关于干预的适应症和最佳时机以及最合适的手术技术的问题仍存在争议。这项工作将综述关于FMR的现有知识,包括其发病机制、可用的治疗策略、试验和观察性研究的证据以及解决其治疗相关问题的潜在未来方向。